glp-1 booster supplement GLP-1 supplement claims: Regulatory considerations
Description
Nearly 42% of adults struggle with weight management, yet many delay GLP-1 therapy because they lack insurance coverage
Ozempic and Mounjaro are still both technically only FDA-approved for the treatment of type 2 diabetes, but many physicians will safely prescribe them off-label for weight loss
51-OR: a phase 2, randomized, double-blind, placebo-controlled, dose-finding study of BI 456906 in people with overweight/obesity
Key Takeaway While GLP-1 medications have shown substantial results in clinical studies, they require a prescription and medical supervision
2021 Jul 25;14(15):4135
Instead of boosting metabolism globally, semaglutide slows stomach emptying, increases feelings of fullness, and reduces hunger signals in the brainallowing patients to eat less without feeling deprived
